CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 30 sources its claims cite is checked for support yet.

Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP

Open access
DeBoer, Scott R., Dolios, Georgia, Wang, Rong, Sisodia, Sangram S. · 2014 · The Journal of Neuroscience

Abstract

The β-amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer's disease. APP is processed in neurons, but little is known about the relative contributions of presynaptic or postsynaptic compartments to the release of Aβ peptides. To address this issue, we transduced primary neurons from Sprague-Dawley rats or APP−/−mice (B6.129S7-App tm1Dbo/J) with lentiviral constructs expressing APP chimeras harboring targeting motifs from low-density lipoprotein receptor or neuron-glia cell-adhesion molecule to polarize expression to either dendritic or axonal membranes, respectively. Using imaging and quantitative biochemical approaches, we now report that APP selectively targeted to either axons or dendrites leads to the secretion of full-length Aβ peptides with significantly elevated release from dendritic compartments. These findings reveal that the enzymatic machinery required for production of Aβ peptides are operative both in presynaptic and postsynaptic compartments of primary neurons, leading to the suggestion that Aβ-mediated impairments in glutamatergic neurotransmission is the result of Aβ release from both local and distal neuronal compartments.

Overview

CoChat Summary

TL;DR

DeBoer et al. used lentiviral APP chimeras targeted to dendrites or axons in primary hippocampal neurons and found that Aβ is released from both compartments, with elevated release from dendritically targeted APP. They also report that neuronal APP is processed mainly by β- and γ-secretases to full-length Aβ species, with Aβ1-40 as the principal secreted peptide and little detectable Aβ17-40/p3.

Key findings

  • APP chimeras were strongly polarized: surface APP-LDLR had axon–dendrite ratios of 0.25 ± 0.04 in rat neurons and 0.19 ± 0.03 in APP−/− mouse neurons, with >80% at the dendritic surface; APP-NgCAM had ratios of 1.95 ± 0.28 and 1.89 ± 0.34, with ~80% at the axonal surface.
  • Aβ was released from both axonal and dendritic compartments, but dendritic APP-LDLR produced more 1-n Aβ than axonal APP-NgCAM or APPΔCterm: APP-LDLR secreted 130.2 ± 15% (p = 0.07 vs APP), APP-NgCAM 61.3 ± 12% (p < 0.01), and APPΔCterm 64.4 ± 11% (p < 0.01) relative to APP. sAPPβ was significantly lower for APP-NgCAM (40.9%, p < 0.05) and APPΔCterm (62.1%, p < 0.05) versus APP.
  • The principal secreted Aβ species was Aβ1-40; human APP produced mainly Aβ1-40, whereas endogenous rat APP produced mainly Aβ11-40. Aβ17-40/p3 was nearly undetectable despite detectable sAPPα and α-CTF, suggesting inefficient neuronal α-CTF processing by γ-secretase.
  • Native surface APP was preferentially axonal (axon–dendrite ratio 1.84 ± 0.28), while intracellular APP was less polarized (1.20 ± 0.12); the M596V/K612V cleavage mutant showed a distribution indistinguishable from native APP.

Methods

  • Primary hippocampal neuron cultures from E18 Sprague-Dawley rats or E17 APP−/− mice (B6.129S7-Apptm1Dbo/J) were transduced at 7 DIV with lentiviral constructs expressing myc-tagged human APP-695 or APP chimeras: APP-LDLR (dendritic targeting), APP-NgCAM (axonal targeting), APPΔCterm, and versions with M596V/K612V mutations.
  • Imaging/immunocytochemistry used live P2-1 surface staining, permeabilized myc-1/MAP2 staining, and copGFP fills; axons and dendrites were traced to quantify axon–dendrite ratios and axonal/dendritic fractions.
  • Conditioned media were analyzed by 35S-methionine metabolic labeling (10 min synthetic rate, 4 h steady-state), immunoprecipitation with 4G8, 6E10, 2G3, or myc-1, Western blotting with 26D6 or 192-WT, and MALDI-TOF mass spectrometry; statistics used unpaired t tests with unequal variance and p < 0.05.

Limitations

  • Stated: the studies examine APP distribution at steady state, so the authors cannot draw conclusions about the trafficking itinerary of the chimeras; live-cell imaging is needed.
  • Stated: it is unclear whether differences in secreted Aβ reflect relative steady-state distribution and/or BACE1 activity; dynamic imaging and neo-epitope-specific antibodies are needed. The authors also note that secreted p3 could be degraded by proteases in conditioned media, though they favor inefficient α-CTF processing.
  • Evident from the text: findings rely on in vitro primary neuron cultures with lentiviral overexpression of chimeric APP constructs, so they may not fully reflect native APP trafficking/processing in vivo; the APP-LDLR increase versus APP was p = 0.07, not below the stated p < 0.05 threshold, and mass spectrometry profiles are semiquantitative.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2255-14.2014

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC-BY-NC-SA · From the PDF
Figure2 APP-M596V/K612Vstaininginprimaryneurons.Neuronsat15DIVcotransfected24hearlierwithplasmidsencoding copGFP and APP-M596V/K612V. When expressed in primary neurons, APP M596V/K612V is found at the cell surface ( A ) and intracellularly ( B ) in both axons and dendrites. APP and APP M596V/K612V expression in HEK293 cells ( C ) shows greatly reduced APP ectodomain shedding when the 𝛂 - and 𝛃 -secretase sites are mutated (left, lystate; right, conditioned medium). Arrows, axons; arrowheads, dendrites.
Figure2 APP-M596V/K612Vstaininginprimaryneurons.Neuronsat15DIVcotransfected24hearlierwithplasmidsencoding copGFP and APP-M596V/K612V. When expressed in primary neurons, APP M596V/K612V is found at the cell surface ( A ) and intracellularly ( B ) in both axons and dendrites. APP and APP M596V/K612V expression in HEK293 cells ( C ) shows greatly reduced APP ectodomain shedding when the 𝛂 - and 𝛃 -secretase sites are mutated (left, lystate; right, conditioned medium). Arrows, axons; arrowheads, dendrites.CC-BY-NC-SA · From the PDF
Figure3 Quantification of protein polarity. A , To quantify protein levels in the processes, the axonal and dendritic arbors were traced, and then these tracings were used to measure APP staining. Theexamplein A is a tracing of the neuron from Figure 1 A . B , C , Ratios of APP staining in axons versus dendrites, as described in text. At the cell surface, both APP ( B ) and APP-M596V/K612Varefound at higher levels in axon then dendrites, but intracellular levels are less polarized ( C ). D , E , The fraction of total APP staining is shown in axonal versus dendritic fractions. At the cell surface ( D ), the majority of APP protein is axonal, but intracellular levels ( E ) are equally split between axons and dendrites.
Figure3 Quantification of protein polarity. A , To quantify protein levels in the processes, the axonal and dendritic arbors were traced, and then these tracings were used to measure APP staining. Theexamplein A is a tracing of the neuron from Figure 1 A . B , C , Ratios of APP staining in axons versus dendrites, as described in text. At the cell surface, both APP ( B ) and APP-M596V/K612Varefound at higher levels in axon then dendrites, but intracellular levels are less polarized ( C ). D , E , The fraction of total APP staining is shown in axonal versus dendritic fractions. At the cell surface ( D ), the majority of APP protein is axonal, but intracellular levels ( E ) are equally split between axons and dendrites.CC-BY-NC-SA · From the PDF
Figure 4 Soluble A 𝛃 peptides derived from APP processing in neurons. A , The alignment of rodent and human A 𝛃 sequences shows 3 aa differences, which allow for distinction between exogenously and endogenously derived A 𝛃 by mass. B , Endogenous APP produces a number of 1n and 11n A 𝛃 species, with 11- 40 being the predominant peptide. In rat neurons ( C ) and APP -/ -mouse neurons ( D ), human APP also produces a number of 1n A 𝛃 species, but only a small amount of 11- 40; **unidentified peak; #rodent A 𝛃 species.
Figure 4 Soluble A 𝛃 peptides derived from APP processing in neurons. A , The alignment of rodent and human A 𝛃 sequences shows 3 aa differences, which allow for distinction between exogenously and endogenously derived A 𝛃 by mass. B , Endogenous APP produces a number of 1n and 11n A 𝛃 species, with 11- 40 being the predominant peptide. In rat neurons ( C ) and APP -/ -mouse neurons ( D ), human APP also produces a number of 1n A 𝛃 species, but only a small amount of 11- 40; **unidentified peak; #rodent A 𝛃 species.CC-BY-NC-SA · From the PDF
Figure 5 Construction of the polarized APP constructs. A , Schematic representation of the different APP chimeric constructs used in this study. The APP cytoplasmic domain was replaced with the entire LDLR (APP-LDLR) or NgCAM (APP-NgCAM) cytoplasmic domains, or was deleted completely (APP 𝚫 Cterm). All constructs contain a myc-tag at the very COOH-terminus. B , Complete cytoplasmic tail sequences of the different APP constructs. 'KKKQ' are the four APP amino acids immediately following the transmembrane domain. Underlined sequences show the LDLR or NgCAM cytoplasmic domains. The myc-tag sequence is MEQKLISEEDLN.
Figure 5 Construction of the polarized APP constructs. A , Schematic representation of the different APP chimeric constructs used in this study. The APP cytoplasmic domain was replaced with the entire LDLR (APP-LDLR) or NgCAM (APP-NgCAM) cytoplasmic domains, or was deleted completely (APP 𝚫 Cterm). All constructs contain a myc-tag at the very COOH-terminus. B , Complete cytoplasmic tail sequences of the different APP constructs. 'KKKQ' are the four APP amino acids immediately following the transmembrane domain. Underlined sequences show the LDLR or NgCAM cytoplasmic domains. The myc-tag sequence is MEQKLISEEDLN.CC-BY-NC-SA · From the PDF
Image 6
CC-BY-NC-SA · From the PDF
Figure 7 APPM596V/K612V chimeras in neurons. Neurons at 15-16 DIV cotransfected 24 h earlier with plasmids encoding copGFP and APPM596V/K612V, APPM596V/K612V-LDLR, APPM596V/K612V-NgCAM, or APPM596V/K612V 𝚫 Cterm. Surfacestaining for APP shows APP-LDLR ( B ) is highly polarized to the dendrites (arrowhead), with little axonal staining (arrow).
Figure 7 APPM596V/K612V chimeras in neurons. Neurons at 15-16 DIV cotransfected 24 h earlier with plasmids encoding copGFP and APPM596V/K612V, APPM596V/K612V-LDLR, APPM596V/K612V-NgCAM, or APPM596V/K612V 𝚫 Cterm. Surfacestaining for APP shows APP-LDLR ( B ) is highly polarized to the dendrites (arrowhead), with little axonal staining (arrow).CC-BY-NC-SA · From the PDF
Figure8 Quantification of A 𝛃 release using S 35 -metabolic labeling. Neurons were transduced with lentiviruses encoding APP, APP-LDLR, APP-NgCAM, or APP 𝚫 Cterm. At 15-16 DIV, A 𝛃 was immunoprecipitated using mAb 4G8 then subject to Western blotting with human-specific mAb 26D6 from the conditioned media of rat neurons ( A ) or mouse APP -/ -neurons ( B ). Less A 𝛃 is seen from APP-NgCAM or APP 𝚫 Cterm compared with APP or APP-LDLR. C , At 15-16 DIV the neurons were labeled with S 35 -methionine for either 10 min or 4 h. APP was immunoprecipitated from the lysates using an anti-myc1 antibody. The APP full-length signal after the 10 min pulse was used to calculate the synthetic rate for each construct. At 4 h, both immature and maturefull-length APP can be seen, as well as APP CTFs. D , A 𝛃 wasimmunoprecipitated from the conditioned media from the 4 h, continuously labeled neurons, using 4G8 (all A 𝛃 species) or the human-specific 6E10 antibody (A 𝛃 1n ). sAPP 𝛂 / 𝛃 + 11 is also shown from the 6E10 IPs. sAPP 𝛃 + 1 is shown by Western blot using the sAPP 𝛃 -specific antibody 192-WT. The same trend for all species is shown in both rat neurons and APP -/ -mouse neurons, similar to the results from IP/Western blot ( A , B ). More A 𝛃 is secreted from the dendritic APP-LDLR construct than from the axonal APP-NgCAM construct. Also, APP 𝚫 Cterm shows less A 𝛃 , as expected, due to the lack of an endocytosis signal. E , Quantification of A 𝛃 1n from rat neuron conditioned media when normalized
Figure8 Quantification of A 𝛃 release using S 35 -metabolic labeling. Neurons were transduced with lentiviruses encoding APP, APP-LDLR, APP-NgCAM, or APP 𝚫 Cterm. At 15-16 DIV, A 𝛃 was immunoprecipitated using mAb 4G8 then subject to Western blotting with human-specific mAb 26D6 from the conditioned media of rat neurons ( A ) or mouse APP -/ -neurons ( B ). Less A 𝛃 is seen from APP-NgCAM or APP 𝚫 Cterm compared with APP or APP-LDLR. C , At 15-16 DIV the neurons were labeled with S 35 -methionine for either 10 min or 4 h. APP was immunoprecipitated from the lysates using an anti-myc1 antibody. The APP full-length signal after the 10 min pulse was used to calculate the synthetic rate for each construct. At 4 h, both immature and maturefull-length APP can be seen, as well as APP CTFs. D , A 𝛃 wasimmunoprecipitated from the conditioned media from the 4 h, continuously labeled neurons, using 4G8 (all A 𝛃 species) or the human-specific 6E10 antibody (A 𝛃 1n ). sAPP 𝛂 / 𝛃 + 11 is also shown from the 6E10 IPs. sAPP 𝛃 + 1 is shown by Western blot using the sAPP 𝛃 -specific antibody 192-WT. The same trend for all species is shown in both rat neurons and APP -/ -mouse neurons, similar to the results from IP/Western blot ( A , B ). More A 𝛃 is secreted from the dendritic APP-LDLR construct than from the axonal APP-NgCAM construct. Also, APP 𝚫 Cterm shows less A 𝛃 , as expected, due to the lack of an endocytosis signal. E , Quantification of A 𝛃 1n from rat neuron conditioned media when normalizedCC-BY-NC-SA · From the PDF
Figure 9 Soluble A 𝛃 peptides detected by mass spectrometry after 4G8 mAb IP. Soluble A 𝛃 peptides derived from APP-chimera processing in mouse APP -/ -neurons ( A-C ) or rat neurons ( D-F ) at 15-16 DIV. A 𝛃 wasimmunoprecipitated using 4G8, and then analyzed using MALDI-TOF mass spectrometry. Spectra from APP-LDLR ( A ), APP-NgCAM ( B ), and APP 𝚫 Cterm( C ) in APP -/ -mouse neurons show a similar profile of A 𝛃 species produced, with 1- 40 as the predominant peptide; *unidentified peak; black peaks, human A 𝛃 . In rat neurons, APP-LDLR ( D ), APP-NgCAM ( E ), and APP 𝚫 Cterm also show a similar profile of A 𝛃 species produced, with 1- 40 as the predominant peptide; *unidentified peak; black peaks, rat A 𝛃 (rA 𝛃 ); red peaks, human A 𝛃 . A 𝛃 17-40 is readily detectable by 4G8 IP followed by MALDI-TOF mass spectrometry ( G -I ). Purified human A 𝛃 1-40 (100 nM, G ; 10 nM, H ) was digested by trypsin, resulting in A 𝛃 17-40 ( G , H ). Additionally, different concentrations of commercially available A 𝛃 17-40 were immunoprecipitated then subjected to mass spectrometry ( I ). M , A 𝛃 17-40 + H, Na, or 2NaH.
Figure 9 Soluble A 𝛃 peptides detected by mass spectrometry after 4G8 mAb IP. Soluble A 𝛃 peptides derived from APP-chimera processing in mouse APP -/ -neurons ( A-C ) or rat neurons ( D-F ) at 15-16 DIV. A 𝛃 wasimmunoprecipitated using 4G8, and then analyzed using MALDI-TOF mass spectrometry. Spectra from APP-LDLR ( A ), APP-NgCAM ( B ), and APP 𝚫 Cterm( C ) in APP -/ -mouse neurons show a similar profile of A 𝛃 species produced, with 1- 40 as the predominant peptide; *unidentified peak; black peaks, human A 𝛃 . In rat neurons, APP-LDLR ( D ), APP-NgCAM ( E ), and APP 𝚫 Cterm also show a similar profile of A 𝛃 species produced, with 1- 40 as the predominant peptide; *unidentified peak; black peaks, rat A 𝛃 (rA 𝛃 ); red peaks, human A 𝛃 . A 𝛃 17-40 is readily detectable by 4G8 IP followed by MALDI-TOF mass spectrometry ( G -I ). Purified human A 𝛃 1-40 (100 nM, G ; 10 nM, H ) was digested by trypsin, resulting in A 𝛃 17-40 ( G , H ). Additionally, different concentrations of commercially available A 𝛃 17-40 were immunoprecipitated then subjected to mass spectrometry ( I ). M , A 𝛃 17-40 + H, Na, or 2NaH.CC-BY-NC-SA · From the PDF
Figure 10 Soluble A 𝛃 peptides derived from APP-chimera processing in rat neurons at 15-16 DIV detected by 2G3 from conditioned media. A 𝛃 was immunoprecipitated using 2G3, then analyzed using MALDI-TOF mass spectrometry. Spectra from APP ( A ), APP-LDLR ( B ), APPNgCAM ( C ), APP 𝚫 Cterm ( D ), and copGFP alone ( E ) in rat neurons show a similar profile of A 𝛃 species produced, with 1- 40 as the predominant exogenous peptide; *unidentified peak; **internal standard; red peaks, human A 𝛃 ; black peaks, rat A 𝛃 (rA 𝛃 ).
Figure 10 Soluble A 𝛃 peptides derived from APP-chimera processing in rat neurons at 15-16 DIV detected by 2G3 from conditioned media. A 𝛃 was immunoprecipitated using 2G3, then analyzed using MALDI-TOF mass spectrometry. Spectra from APP ( A ), APP-LDLR ( B ), APPNgCAM ( C ), APP 𝚫 Cterm ( D ), and copGFP alone ( E ) in rat neurons show a similar profile of A 𝛃 species produced, with 1- 40 as the predominant exogenous peptide; *unidentified peak; **internal standard; red peaks, human A 𝛃 ; black peaks, rat A 𝛃 (rA 𝛃 ).CC-BY-NC-SA · From the PDF

Verification

Claims the paper makes

0 Valid · 0 Not valid · 19 Not checked · 84 Own results and interpretations

63 more claims

Create a free account to see all 103 claims and to verify the 28 references still open.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 14
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 40 references

Cited by

See all 51

Metadata

Authors
DeBoer, S. R., Dolios, G., Wang, R., & Sisodia, S. S.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • University of Chicago (US)
Corresponding author
Sisodia, Sangram S.
Venue
The Journal of Neuroscience
Published
2014-09-10
Volume
34
Issue
37
Pages
12313-12327
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1967673679
Cited by
51
References
40
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 1
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
Funders
  • Cure Alzheimer's Fund
  • Eisai
  • National Institutes of Health
  • National Institute on Aging (F30AG034001)
  • National Institute of Neurological Disorders and Stroke (P30NS061777)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
amyloid-beta, amyloid precursor protein, dendrites, axons, Alzheimer's disease, glutamatergic neurotransmission, APP knockout mice, lentiviral transduction, APP processing
MeSH terms
Animals, Axons, Cells, Cultured, Dendrites, Female, Male, Tissue Distribution, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Presynaptic Terminals, Mice, Knockout, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP. https://app.cochat.ai/papers/10.1523/jneurosci.2255-14.2014
The paper
DeBoer, S. R., Dolios, G., Wang, R., & Sisodia, S. S. (2014). Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2255-14.2014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.